Related Experiment Video
Updated: Jan 23, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Conophylline: a novel differentiation inducer for pancreatic beta cells
1Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan. ikojima@showa.gunma-u.ac.jp
Abstract:
Reduction of the beta cell mass is critical in the pathogenesis of diabetes mellitus. The discovery of agents, which induce differentiation of pancreatic progenitors to beta cells, would be useful to develop a new therapeutic approach to treat diabetes. To identify a new agent to stimulate differentiation of pancreatic progenitor cells to beta cells, we screened various compounds using pancreatic AR42J cells, a model of pancreatic progenitor cells. Among various compounds and extracts tested, we found that conophylline, a vinca alkaloid extracted from leaves of a tropical plant Ervatamia microphylla, was effective in converting AR42J into endocrine cells. Conophylline reproduces the differentiation-inducing activity of activin A. Unlike activin A, however, conophylline does not induce apoptosis. To induce differentiation of AR42J cells, conophylline increases the expression of neurogenin-3 by activating p38 mitogen-activated protein kinase. Conophylline also induces differentiation in cultured pancreatic progenitor cells obtained from fetal and neonatal rats. More importantly, conophylline is effective in reversing hyperglycemia in neonatal streptozotocin-treated rats, and both the insulin content and the beta cell mass are increased by conophylline. Histologically, conophylline increases the numbers of ductal cells positive for pancreatic-duodenal-homeobox protein-1 and islet-like cell clusters. Conophylline and related compounds are useful in inducing differentiation of pancreatic beta cells both in vivo and in vitro.
Insights
Conophylline, a plant-derived compound, effectively converts pancreatic progenitor cells into insulin-producing beta cells. This discovery offers a promising new therapeutic strategy for treating diabetes by increasing beta cell mass.
Area of Science:
- Endocrinology
- Cell Biology
- Pharmacology
Background:
- Diabetes mellitus is characterized by a reduced beta cell mass.
- New therapeutic strategies are needed to stimulate beta cell regeneration.
Purpose of the Study:
- To identify novel agents that promote pancreatic progenitor cell differentiation into beta cells.
- To evaluate the therapeutic potential of conophylline for diabetes treatment.
Main Methods:
- Screening of various compounds using AR42J pancreatic progenitor cells.
- Investigating conophylline's mechanism of action, including gene expression and kinase activation.
- Assessing conophylline's efficacy in vitro and in vivo using rodent models of diabetes.
Main Results:
- Conophylline induced differentiation of AR42J cells and primary pancreatic progenitor cells into endocrine cells.
- Conophylline increased neurogenin-3 expression via p38 MAPK activation, without inducing apoptosis.
- Conophylline reversed hyperglycemia in diabetic rats, increasing insulin content and beta cell mass.
Conclusions:
- Conophylline is a potent inducer of pancreatic beta cell differentiation and regeneration.
- Conophylline represents a promising therapeutic candidate for diabetes treatment.
- Further research into conophylline and related compounds could lead to novel diabetes therapies.
Related Concept Videos
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
iPS Cell Differentiation
Differentiation of Common Myeloid Progenitor Cells
Pancreatic Juice and Secretion
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...

